Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lundbeck Cuts Its European Sales Teams By A Third, As It Builds Up Its Presence In the U.S. And Emerging Markets

This article was originally published in The Pink Sheet Daily

Executive Summary

Lundbeck becomes the latest company in Europe to announce job cuts, as austerity, generic competition and unclear pricing and reimbursement practices create uncertainties.

Advertisement

Related Content

Lundbeck Pins Hopes On New Product Launches, Ex-Europe Growth To Reverse Revenue Drain
AstraZeneca Goes Virtual In Neuroscience R&D As Part Of Workforce Reduction
For Novartis, 2012 Is Set To Be A Bumpy Ride
Lundbeck/Otsuka Global Alliance Will Support Lundbeck's Move Into U.S. Psychiatry Market
Lundbeck Cuts 150 R&D Jobs To Control Costs Ahead Of Key Patent Expiry

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel